Tests show 2-year benefits of Merck diabetes drug (Reuters)

Reuters - Merck & Co's diabetes drug Januvia substantially improves blood sugar levels over two years of treatment when combined with the older drug metformin and is generally well tolerated, new data on Tuesday showed.